Error: Could not add to watchlist. X

AVEO Pharmaceuticals Inc

+ Watchlist
AVEO:US
NASDAQ GS
2.25
USD
0.12
5.21%
As of 11:43:37 ET on 06/03/2015.
Open
2.39
Day Range
2.21 - 2.39
Volume
1,380,407
Previous Close
2.37
52Wk Range
0.61 - 3.50
1 Yr Return
116.02%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.89
Market Cap (m USD)
124.453
Shares Outstanding (m)
55.070
Price/Sales (TTM)
39.17
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Aveo Pharmaceuticals Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics. The Company's lead product candidate is an oral inhibitor of the vascular endothelial growth factor, or VEGF,receptors.
ADDRESS
650 East Kendall Street
Cambridge, MA 02142
United States
PHONE
1-617-299-5000
  • Michael P Bailey
    President/CEO
  • Keith S Ehrlich
    Chief Financial Officer
  • Michael N Needle
    Chief Medical Ofcr:Aveo Oncology
  • Joseph Vittiglio
    Senior VP/General Counsel
Show More